Assessment of cardiovascular risk factors in patients with idiopathic inflammatory myopathies: a systematic review
- PMID: 37191898
- DOI: 10.1007/s10067-023-06633-5
Assessment of cardiovascular risk factors in patients with idiopathic inflammatory myopathies: a systematic review
Abstract
We performed a systematic review of cardiovascular risk factors in idiopathic inflammatory myopathies (IIMs) and their cardiovascular outcomes, including acute coronary syndrome and stroke. A qualitative systematic review was conducted from January 1956 to December 2022 according to the PRISMA protocol using three electronic databases: PubMed, Web of Science, and Scopus. The studies were analyzed based on the following eligibility criteria: at least one combination of the terms described in the search strategy appeared in the title, written in English, Portuguese, or Spanish, and addressed risk factors for cardiovascular diseases in IIMs. Brief reports, reviews, papers addressing juvenile IIMs, congress proceedings, monographs, and dissertations were excluded. Twenty articles were included. According to the literature, most patients with IIMs are middle-aged North American or Asian women, with dyslipidemia and hypertension. The prevalence of the cardiovascular risk factors was generally low in IIMs, but with a high incidence of acute myocardial infarction. Further theoretical and prospective studies are needed to define the actual impact of each variable (e.g., hypertension, diabetes, smoking, alcoholism, obesity, and dyslipidemia) on the cardiovascular risk of patients with IIMs.
Keywords: Cardiovascular risk; Dermatomyositis; Idiopathic inflammatory myositis; Myositis; Polymyositis.
© 2023. The Author(s), under exclusive licence to International League of Associations for Rheumatology (ILAR).
References
-
- Lundberg I, Fujimoto M, Vencovsky J et al (2021) Idiopathic inflammatory myopathies. Nat Rev Dis Primers 7:86. https://doi.org/10.1038/s41572-021-00321-x - DOI - PubMed
-
- Cavagna L, Araguás-Trallero E, Meloni F et al (2019) Influence of antisynthetase antibodies specificities on antisynthetase syndrome clinical spectrum time course. J Clin Med 8:2013. https://doi.org/10.3390/jcm8112013
-
- Mammen A, Chung T, Christopher-Stine L et al (2011) Autoantibodies against 3-hydroxy-3-methylglutaryl-coenzyme A reductase in patients with statin-associated autoimmune myopathy. Arthritis Rheum 63:713–721. https://doi.org/10.1002/art.30156 - DOI - PubMed - PMC
-
- Párraga Prieto C, Ibrahim F, Campbell R, Chinoy H, Galloway J, Gordon P (2021) Similar risk of cardiovascular events in idiopathic inflammatory myopathy and rheumatoid arthritis in the first 5 years after diagnosis. Clin Rheumatol 40:231–238. https://doi.org/10.1007/s10067-020-05237-7 - DOI - PubMed
-
- Oreska S, Storkanova H, Kudlicka J et al (2022) Cardiovascular risk in myositis patients compared to the general population: preliminary data from a single-center cross-sectional study. Front Med (Lausanne) 9:861419. https://doi.org/10.3389/fmed.2022.861419
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical